Patients will have the opportunity to enroll in a new program to determine how Propeller's hi-tech tool can impact adherence rates and patient engagement.
Researchers plan to recruit 675 adults to investigate the safety and efficacy of three different treatment regimens for mild asthma.
The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.
In the game, kids care for their pet's asthma, while learning about inhaler technique and timing, trigger identification and avoidance.
The two companies have created the platform that combines adherence and lung function measurement with medication management services.
The company's connected devices and mobile apps engage and empower respiratory patients by measuring lung function and tracking adherence.
The four-year grant is part of a national $144 million initiative called Pediatric Research using Integrated Sensor Monitoring Systems or PRISMS.
GSK will use the sensor in the studies to automatically collect and record data on the inhaler's usage, and wirelessly transmit the data collected.
The device will monitor air quality, CO2 levels in the blood, physical activity, breathing, emotional states and other stimuli to identify asthma triggers.
Featuring medical-grade accuracy, the device has been launched on crowdfunding website Indiegogo, with the goal of raising $50,000 in a month-long campaign.